The controversy over the efficacy of pneumococcal vaccine

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 1, 2009, Pages 18-19

  Andrews, Ross ^a   Moberley, Sarah A ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTEREMIA; CLINICAL TRIAL; DRUG EFFICACY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; NOTE; QUALITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIA; VACCINATION; WORLD HEALTH ORGANIZATION; ADULT; CHILD; HERD IMMUNITY; IMMUNOLOGY; PNEUMONIA;

ADULT; CHILD; HUMANS; IMMUNITY, HERD; IMMUNIZATION SCHEDULE; PNEUMOCOCCAL VACCINES; PNEUMONIA;

EID: 58849146253     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081744     Document Type: Note

References (8)

1. Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009;180:48-58.
2. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
3. Kaufman P. Pneumonia in old age. Arch Intern Med 1947;79:518-31.
4. Riley ID, Tarr PI, Andrews M, et al. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1977;1:1338-41.
5. Honkanen PO, Keistinen T, Miettinen L, et al. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999;17:2493-500.
6. Lexau CA, Lynfield R, Danila R, et al.; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294:2043-51.
7. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-92.
8. World Health Organization. 23-valent pneumococcal polysaccharide vaccine [position paper]. Wkly Epidemiol Rec 2008;83:373-84. Available: www.who.int/wer/2008/wer8342.pdf (accessed 2008 Nov 13).